spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

IRT Europe Summit

IRT_Europe_2018

10-11 April 2018
The Hotel Brussels, Belgium

New clinical trial regulations are requiring sponsors to keep tighter oversight than ever before – from audit trails to tracking system changes – resulting in high costs and trial delays. IRT Europe explores implementation best practices and how interactive response technologies can be utilised to improve supply chain planning and optimise clinical trials. Take this opportunity to share and discuss current industry needs, the latest tools and solutions for forecasting and the various regulatory requirements for IRT, among many other critical topics.

Pivotal Discussions, Unparalleled Insights and Expert Commentary Including:

  • Streamline IRT operations to ensure supply chain agility
  • Leverage end-to-end IRT for drug accountability and returns
  • Discuss the shift to standardisation to overcome challenges
    of building custom systems
  • Assess best practices for obtaining site feedback and
    leveraging it to drive simplicity in clinical trials
  • Explore the growing need for temperature monitoring
    of clinical supplies
  • Identify innovative approaches to integrate eSource
    and IRT to simplify the site experience
  • Facilitate web-based tools to expand IRT systems
    and avoid duplicate enrollment
  • Examine IRT and its role in patient randomisation
phone +1-339-298-2127
email Thomas.Zekos@cbinet.com
web www.cbinet.com/IRTEU
email The Hotel Brussels, Belgium
 
Print this page
Send to a friend
   
spacer
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

White Papers

Maximize the ROI of Your Post-Approval Research

Bioclinica

Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment. Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >>


News and Press Releases

IONTAS announces a new collaboration to identify novel immunotherapy targets

Cambridge, UK, 07 May 2020: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Inotrem, a specialist in immunotherapy for acute and chronic inflammatory syndromes. As part of the agreement, IONTAS will apply its Mammalian Display technology to identify antibodies involved in the TREM-1 pathway.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement